Article Listing - Ariad reports progress with osteoporosis drug

FORTHCOMING MEETINGS FROM IBC

13 April 1992

IBC Technical Services Ltd is organizing the following industry-related conferences over the next few months:

- Strategies, Costs and Timing: The...

FRENCH HEALTH SPENDING RISE

13 April 1992

French health care spending by the CNAM insurance fund rose 0.3% between December 1991 and January 1992. Spending in January...

STRONG EXPANSION AT KNOLL IN 1991

13 April 1992

The drug-making arm of the German chemical concern BASF, Knoll AG, has reported a 9% expansion of sales worldwide...

EC TRADEMARKS/ PATENTS CONGRESS

13 April 1992

The second European congress on patents, trademarks and innovation, Pattinova '92, is scheduled to take place May 18-20 in Lisbon,...

GENZYME SEEKING EURO APPROVAL OF CEREDASE

13 April 1992

Presently approved in the USA as an enzyme replacement therapy for patients with Gaucher disease type I, Genzyme Corp's Ceredase...

IDEC PHARMA'S ANTIBODY THERAPY

13 April 1992

IDEC Pharmaceuticals reports that it has developed a "primatized" antibody which could improve the treatment of several chronic diseases. The...

PATENT INFRINGEMENT SUIT OVER SANDOZ' ZADITEN

13 April 1992

The Tokyo District Court has issued a preliminary injunction against Kyowa Yakuhin Kogyo, Tatsumi Kagaku and Ohara Yakuhin Kogyo with...

S-P HEALTHCARE PRODUCTS CANADA

13 April 1992

At Schering-Plough Health-Care Products Canada Inc, George Cugini moves up to vice president, marketing, from marketing director, seasonal products. Dan...

EC APPROVAL FOR DOVONEX

13 April 1992

Denmark's Leo Laboratories has been granted marketing approval from the European Community's Committee for Proprietary Medicinal Products for its psoriasis...

FUJISAWA TAIWAN PLANT PLANNED

13 April 1992

Japan's Fujisawa Pharmaceutical says its 80%-owned Taiwan-based affiliate is to start construction of a new manufacturing plant at the company's...